To investigate whether the tumor promoting activity of LRIG2 is ERBB receptor‐dependent, we analyzed the expression of the latter and respective downstream targets in transgenic and control skin during two‐stage skin carcinogenesis. Here, LRIG2 is linked to neoplasm.